• Issues
    • Current Issue
    • Special Issues
  • Viewpoints
    • Editor’s Corner
    • Advanced Practice Voices
    • From Our Readers
      • You Make the Call: Readers’ Response
      • Guest Commentary
      • Letters to the Editor
    • Notes From the Hill
    • The Break Room
  • Education
    • You Make the Call
    • How I Teach
    • How I Treat In Brief
    • Demystifying the Lab
    • Practice Update
  • Spotlight
    • Feature Articles
    • Pulling Back the Curtain
    • Blood Beyond Borders
    • pASHions
    • Drawing First Blood
    • Interviews
  • News
    • Online Exclusives
    • Latest & Greatest
    • From the Blood Journals
      • Written in Blood
      • Blood Advances in a Different Vein
    • Literature Scan
    • ASH Directions
    • The Society Pages
  • Topic Compilations
    • COVID-19 News
    • Acute Leukemias
    • Chronic Leukemias
    • MDS & Myeloproliferative Neoplasms
    • Multiple Myeloma & Plasma Cell Disorders
    • Lymphomas & Lymphoid Neoplasia
    • Bleeding Disorders
    • Clotting Disorders
    • Red Blood Cell & Iron Disorders
  • On Location
    • ASH Annual Meeting
    • ASH Meeting on Hematologic Malignancies
    • ASH Meeting on Lymphoma Biology
    • Other Meetings
  • Multimedia
    • Sound Bites
    • Meeting Coverage
Search
  • ASH Home
  • About ASH Clinical News
  • Authors
  • Advertising
  • Subscribe
  • Contact Us
  • eNewsletters
  • Cookie Settings
  • LOG IN
Welcome! Log into your account
Forgot your password?
Recover your password
ASH Clinical News
  • Issues
    • AllCurrent IssueSpecial Issues

      July 2020 Volume 6 Issue 8

      June 2020, Volume 6, Issue 7

      Focus on Myeloid Malignancies (Volume 6, Issue 6.1)

      May 2020, Volume 6, Issue 6

  • Viewpoints
    • Editor’s Corner
    • Advanced Practice Voices
    • From Our Readers
      • You Make the Call: Readers’ Response
      • Guest Commentary
      • Letters to the Editor
    • Notes From the Hill
    • The Break Room
  • Education
    • You Make the Call
    • How I Teach
    • How I Treat In Brief
    • Demystifying the Lab
    • Practice Update
  • Spotlight
    • Feature Articles
    • Pulling Back the Curtain
    • Blood Beyond Borders
    • pASHions
    • Drawing First Blood
    • Interviews
  • News
    • Online Exclusives
    • Latest & Greatest
    • From the Blood Journals
      • Written in Blood
      • Blood Advances in a Different Vein
    • Literature Scan
    • ASH Directions
    • The Society Pages
  • Topic Compilations
    • COVID-19 News
    • Acute Leukemias
    • Chronic Leukemias
    • MDS & Myeloproliferative Neoplasms
    • Multiple Myeloma & Plasma Cell Disorders
    • Lymphomas & Lymphoid Neoplasia
    • Bleeding Disorders
    • Clotting Disorders
    • Red Blood Cell & Iron Disorders
  • On Location
    • ASH Annual Meeting
    • ASH Meeting on Hematologic Malignancies
    • ASH Meeting on Lymphoma Biology
    • Other Meetings
  • Multimedia
    • Sound Bites
    • Meeting Coverage
Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages
Home Issue Archive
  • Issue Archive

February 2015

Saturday, June 20, 2015

SHARE
admin
Advertisement

Recent Articles

Oral Apixaban Noninferior to Subcutaneous Dalteparin for Preventing Recurrent Cancer-Associated VTE

Wednesday, July 1, 2020
In patients with cancer-associated venous thromboembolism (VTE), treatment with oral apixaban was noninferior to subcutaneous dalteparin for the prevention of recurrent VTE, according to...

July 2020 Volume 6 Issue 8

Wednesday, July 1, 2020
This issue discusses palliative care and hematopoietic cell transplant, examines anticoagulation in patients with obesity, and more.
How I Treat In Brief

How I Treat in Brief: Anticoagulation in Patients With Obesity

Wednesday, July 1, 2020
This month, Tzu-Fei Wang, MD, and Marc Carrier, MD, MSc, reviewed anticoagulation strategies for patients who are obese and therefore at risk of venous thromboembolism, atrial...

Daratumumab and Hyaluronidase-fihj Approved For Patients With Myeloma

Wednesday, July 1, 2020
The FDA has approved a new subcutaneous formulation of daratumumab and hyaluronidase-fihj for adult patients with newly-diagnosed or relapsed/refractory multiple myeloma (MM). Daratumumab was...
You Make the Call

You Make the Call: Should this patient with DLBCL receive rituximab maintenance after R-CHOP?

Wednesday, July 1, 2020
This month Ann S. LaCasce, MD, MMSc, discusses whether a patient with high-risk DLBCL should receive rituximab maintenance after R-CHOP (rituximab, cyclophosphamide, doxorubicin hydrochloride,...

Current Issue

July 2020 Volume 6 Issue 8

Wednesday, July 1, 2020
This issue discusses palliative care and hematopoietic cell transplant, examines anticoagulation in patients with obesity, and more.
Related Articles
Recent Posts
  • Oral Apixaban Noninferior to Subcutaneous Dalteparin for Preventing Recurrent Cancer-Associated VTE
  • How I Treat in Brief: Anticoagulation in Patients With Obesity
  • Daratumumab and Hyaluronidase-fihj Approved For Patients With Myeloma
  • You Make the Call: Should this patient with DLBCL receive rituximab maintenance after R-CHOP?

Meeting Coverage

MLL Associated With Worse Post-Transplant Outcomes Than Other Cytogenetic Factors

Friday, May 1, 2020

Study Examines Trends in Real-World Treatment Sequencing Patterns for CLL/SLL

Sunday, March 1, 2020

Editor`s Corner

Editor’s Corner: Caring For Ourselves and Each Other in an Unprecedented...

Wednesday, July 1, 2020

Editor’s Corner: We Will Fly Again!

Monday, June 1, 2020
2021 L Street NW, Suite 900, Washington, DC 20036
Phone 202-776-0544 | Fax 202-776-0545
  • ASH Home
  • Research
  • Education
  • Advocacy
  • Meetings
  • Publications
  • ASH Store
Copyright © 2020 by American Society of Hematology

Contact Us | Terms of Service | Privacy Policy